胸腺瘤相关的自身免疫脑炎与肌痛神经衰竭:病例系列和文献综述
Miao Su1, Qiuyan Luo1,2, Zichao Wu1
1Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
CNS neuroscience & therapeutics
|February 29, 2024
概括
这份关于胸腺瘤相关的自身免疫脑炎 (AE) 和肌痛性脑膜炎 (MG) 的综述发现,AE发作可以在胸腺瘤复发之前发生. 早期发现和治疗对于管理这些复杂的疾病至关重要.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 胸腺瘤是胸腺的原发性瘤,与各种类脑膜瘤综合征有关.
- 自身免疫性脑炎 (AE) 和肌痛性骨髓灰质炎 (MG) 是自身免疫性疾病,可发生在患有胸腺瘤的患者中.
- 了解胸腺瘤,AE和MG之间的相互作用对于诊断和管理至关重要.
研究的目的:
- 编制和分析诊断出AE和MG的胸腺瘤患者的病例.
- 描述这些患者的临床特征和结果.
- 为了研究胸腺瘤,AE和MG之间的关系.
主要方法:
- 对从1990年1月到2022年6月的病例报告进行了全面的文献搜索.
- 审查了三名被诊断患有胸腺瘤,AE和MG的局部患者的临床记录.
- 总共有18个病例被纳入了这项分析.
主要成果:
- 所有18名患者都有阳性抗乙胆受体抗体 (AChR-Ab).
- 5/18名患者对α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic酸受体抗体 (AMPAR-Ab) 的检测结果呈阳性.
- 12/18名患者对甲状腺切除术和免疫治疗有积极反应,AE发作有时会在甲状腺瘤复发之前出现.
结论:
- 与胸腺瘤相关的自身免疫脑炎 (TAAE) 经常与AMPAR2-Ab.
- AE发作比MG发作更频繁地表明胸腺瘤复发.
- 甲状腺切除术相对于MG或AE发作的时间影响甲状腺瘤复发和患者的预后.
关键词:
自身免疫性脑炎的发生.肌痛性骨髓灰质炎 (Myasthenia Gravis) 是一个严重的疾病.甲状腺切除术 (thymectomy) 是一种切除术.蒂莫莫马马 (thymomaoma) 是一种疾病.更多相关视频
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.2K
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
3.5K
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831
Disorders of the Skeletal Muscle
946
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
946
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
